NCT06071754View on ClinicalTrials.gov

Validation of the Performance of the Electrocardiogram (ECG) Function in the Masimo INVSENSOR00057

NACompletedINTERVENTIONAL
Enrollment

365

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2024

Conditions
HealthyAtrial Fibrillation
Interventions
DEVICE

Masimo INVSENSOR00057

Masimo INVSENSOR00057 will be used to collect electrocardiogram measurements.

Trial Locations (4)

27401

Cone Health, Greensboro

27405

Medication Management, Greensboro

92618

Masimo Clinical Lab, Irvine

92653

PCA Cardiology, Laguna Hills

Sponsors

Lead Sponsor

Masimo Corporation
All Listed Sponsors
lead

Masimo Corporation

INDUSTRY